Literature DB >> 10757548

Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells.

B S McIntyre1, K P Briski, M A Tirmenstein, M W Fariss, A Gapor, P W Sylvester.   

Abstract

Studies were conducted to determine the comparative effects of tocopherols and tocotrienols on normal mammary epithelial cell growth and viability. Cells isolated from midpregnant BALB/c mice were grown within collagen gels and maintained on serum-free media. Treatment with 0-120 microM alpha- and gamma-tocopherol had no effect, whereas 12.5-100m microM tocotrienol-rich fraction of palm oil (TRF), 100-120 microM delta-tocopherol, 50-60 microM alpha-tocotrienol, and 8-14 microM gamma- or delta-tocotrienol significantly inhibited cell growth in a dose-responsive manner. In acute studies, 24-h exposure to 0-250 microM alpha-, gamma-, and delta-tocopherol had no effect, whereas similar treatment with 100-250 microM TRF, 140-250 microM alpha-, 25-100 microM gamma- or delta-tocotrienol significantly reduced cell viability. Growth-inhibitory doses of TRF, delta-tocopherol, and alpha-, gamma-, and delta-tocotrienol were shown to induce apoptosis in these cells, as indicated by DNA fragmentation. Results also showed that mammary epithelial cells more easily or preferentially took up tocotrienols as compared to tocopherols, suggesting that at least part of the reason tocotrienols display greater biopotency than tocopherols is because of greater cellular accumulation. In summary, these findings suggest that the highly biopotent gamma- and delta-tocotrienol isoforms may play a physiological role in modulating normal mammary gland growth, function, and remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757548     DOI: 10.1007/BF02664767

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  44 in total

Review 1.  Introduction: nutritional aspects of palm oil.

Authors:  R C Cottrell
Journal:  Am J Clin Nutr       Date:  1991-04       Impact factor: 7.045

2.  Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.

Authors:  B Zhao; W Yu; M Qian; M Simmons-Menchaca; P Brown; M J Birrer; B G Sanders; K Kline
Journal:  Mol Carcinog       Date:  1997-07       Impact factor: 4.784

3.  Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.

Authors:  J M Turley; F W Ruscetti; S J Kim; T Fu; F V Gou; M C Birchenall-Roberts
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

4.  Study of apoptosis in peripheral blood of patients with acute lymphoblastic leukemia during induction therapy.

Authors:  G T Tsangaris; M Moschovi; V Mikraki; E Vrachnou; F Tzortzatou-Stathopoulou
Journal:  Anticancer Res       Date:  1996 Sep-Oct       Impact factor: 2.480

5.  Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs.

Authors:  A Hosomi; M Arita; Y Sato; C Kiyose; T Ueda; O Igarashi; H Arai; K Inoue
Journal:  FEBS Lett       Date:  1997-06-02       Impact factor: 4.124

6.  RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.

Authors:  W Yu; B G Sanders; K Kline
Journal:  Nutr Cancer       Date:  1997       Impact factor: 2.900

7.  Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells.

Authors:  S J Nass; M Li; L T Amundadottir; P A Furth; R B Dickson
Journal:  Biochem Biophys Res Commun       Date:  1996-10-03       Impact factor: 3.575

8.  Sensitive method for measuring tissue alpha-tocopherol and alpha-tocopheryloxybutyric acid by high-performance liquid chromatography with fluorometric detection.

Authors:  M A Tirmenstein; B W Watson; N C Haar; M W Fariss
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-04-10

9.  Effect of alpha tocopheryl succinate on cyclic AMP-dependent protein kinase activity in murine B-16 melanoma cells in culture.

Authors:  S Torelli; F Masoudi; K N Prasad
Journal:  Cancer Lett       Date:  1988-03       Impact factor: 8.679

10.  Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells.

Authors:  K Heermeier; M Benedict; M Li; P Furth; G Nuñez; L Hennighausen
Journal:  Mech Dev       Date:  1996-05       Impact factor: 1.882

View more
  38 in total

1.  Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment.

Authors:  Amit B Shirode; Paul W Sylvester
Journal:  J Bioanal Biomed       Date:  2011-01-10

2.  Tocotrienols and breast cancer: the evidence to date.

Authors:  Kalanithi Nesaretnam; Puvaneswari Meganathan; Sheela Devi Veerasenan; Kanga Rani Selvaduray
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

3.  Tocotrienols fight cancer by targeting multiple cell signaling pathways.

Authors:  Ramaswamy Kannappan; Subash C Gupta; Ji Hye Kim; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-09       Impact factor: 5.523

4.  Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells.

Authors:  Paola Palozza; Sara Verdecchia; Luca Avanzi; Silvia Vertuani; Simona Serini; Anna Iannone; Stefano Manfredini
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

5.  γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.

Authors:  R A Ahmed; O A Alawin; P W Sylvester
Journal:  Cell Prolif       Date:  2016-06-21       Impact factor: 6.831

6.  Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation.

Authors:  P W Sylvester; B S McIntyre; A Gapor; K P Briski
Journal:  Cell Prolif       Date:  2001-12       Impact factor: 6.831

7.  Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.

Authors:  Amit B Shirode; Paul W Sylvester
Journal:  Biomed Pharmacother       Date:  2009-11-14       Impact factor: 6.529

8.  Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.

Authors:  Sunitha V Bachawal; Vikram B Wali; Paul W Sylvester
Journal:  BMC Cancer       Date:  2010-03-08       Impact factor: 4.430

9.  Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression.

Authors:  G V Samant; V B Wali; P W Sylvester
Journal:  Cell Prolif       Date:  2009-11-17       Impact factor: 6.831

10.  Deposition of tocopherol and tocotrienol in the tissues of red hybrid tilapia, Oreochromis sp., fed vitamin E-free diets supplemented with different plant oils.

Authors:  Kuan-Shern Lee; Kah-Hay Yuen; Wing-Keong Ng
Journal:  Fish Physiol Biochem       Date:  2013-04-20       Impact factor: 2.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.